MedPath

Randomized controlled trial for the prevention of colorectal tumor recurrence by vitamin D and calcium supplementatio

Phase 3
Recruiting
Conditions
colorectal tumor
Registration Number
JPRN-UMIN000004854
Lead Sponsor
ational Center for Global Health and Medicine, Clinical Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with familial polyposis coli, hereditary nonpolyposis colorectal cancer, ulcerative colitis 2) Patients who have undergone surgical resection of the colorectum 3) Patients who use vitamin D (400IU or greater per day) supplement 4) Patients who take non-steroidal anti-inflammatory drugs 3 times or more per week 5) Patients who take vitamin D or calcium supplement as prescribed by a doctor 6) Patients with a history of cancer (excluding those with a history of curative resection of early colorectal cancer or cancer of site other than the colorectum), cerebrovascular events, urinary tract stone, chronic kidney disease, thyroid disease, chronic liver disease (chronic hepatitis, liver cirrhosis), psychiatric disease 7) Patients who have known or anticipated difficulties for study participation throughout study period 8) Patients who are judged by his/her doctor to be unsuitable for study participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath